Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Iselin, NJ
SEC filing record 1 source field available
Fiscal year end
30 September
Outlook Therapeutics, Inc. has filed 815 SEC EDGAR filings since 10 Aug 2015

SEC filing history

Showing 676-700 of 815 matching filings.

Per page
25
Current page
28
PRER14A File 001-37759

PRELIMINARY PROXY STATEMENT

Filing date
27 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
26 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-295363

D filing

Filing date
25 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

OWNERSHIP DOCUMENT

Filing date
25 Sep 2017
Reporting date
07 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
18 Sep 2017
Reporting date
11 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
18 Sep 2017
Reporting date
11 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
18 Sep 2017
Reporting date
07 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-89495

SCHEDULE 13D

Filing date
18 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-37759

PRELIMINARY PROXY STATEMENT

Filing date
14 Sep 2017
Reporting date
14 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
11 Sep 2017
Reporting date
07 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-216610

PROSPECTUS SUPPLEMENT NO. 2

Filing date
15 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-216080

PROSPECTUS SUPPLEMENT NO. 2

Filing date
15 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-209011

PROSPECTUS SUPPLEMENT NO. 4

Filing date
15 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-212351

PROSPECTUS SUPPLEMENT NO. 4

Filing date
15 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

8-K

Filing date
31 Jul 2017
Reporting date
25 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
05 Jul 2017
Reporting date
28 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

8-K

Filing date
15 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-216610

PROSPECTUS SUPPLEMENT NO. 1

Filing date
16 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-216080

PROSPECTUS SUPPLEMENT NO. 1

Filing date
16 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-209011

PROSPECTUS SUPPLEMENT NO. 3

Filing date
16 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-212351

PROSPECTUS SUPPLEMENT NO. 3

Filing date
16 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89495

SC 13G

Filing date
24 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
17 Apr 2017
Reporting date
13 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .